510(k) K152343

Direct Bilirubin by Randox Laboratories Limited — Product Code JFM

K152343 is an FDA 510(k) premarket notification submitted by Randox Laboratories Limited for the device "Direct Bilirubin". The FDA issued a decision of Substantially Equivalent on February 16, 2016. The device falls under product code JFM (Enzymatic Method, Bilirubin), a Class II device regulated under 21 CFR 862.1110. Randox Laboratories Limited has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 16, 2016
Date Received
August 19, 2015
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzymatic Method, Bilirubin
Device Class
Class II
Regulation Number
862.1110
Review Panel
CH
Submission Type